Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders - PubMed (original) (raw)
. 2007 May 8;104(19):8131-6.
doi: 10.1073/pnas.0702157104. Epub 2007 May 1.
Joshua C Murtie, Bassem F El-Khodor, Nicole Edgar, S Pablo Sardi, Bryan M Hooks, Marianne Benoit-Marand, Chinfei Chen, Holly Moore, Patricio O'Donnell, Daniela Brunner, Gabriel Corfas
Affiliations
- PMID: 17483467
- PMCID: PMC1876583
- DOI: 10.1073/pnas.0702157104
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders
Kristine Roy et al. Proc Natl Acad Sci U S A. 2007.
Abstract
Several psychiatric disorders are associated with white matter defects, suggesting that oligodendrocyte (OL) abnormalities underlie some aspects of these diseases. Neuregulin 1 (NRG1) and its receptor, erbB4, are genetically linked with susceptibility to schizophrenia and bipolar disorder. In vitro studies suggest that NRG1-erbB signaling is important for OL development. To test whether erbB signaling contributes to psychiatric disorders by regulating the structure or function of OLs, we analyzed transgenic mice in which erbB signaling is blocked in OLs in vivo. Here we show that loss of erbB signaling leads to changes in OL number and morphology, reduced myelin thickness, and slower conduction velocity in CNS axons. Furthermore, these transgenic mice have increased levels of dopamine receptors and transporters and behavioral alterations consistent with neuropsychiatric disorders. These results indicate that defects in white matter can cause alterations in dopaminergic function and behavior relevant to neuropsychiatric disorders.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Fig. 1.
Transgene expression is specific to OL lineage cells. (a) Western blot analysis of spinal cord lysates shows that the time course of DN-erbB4 expression closely resembles that of myelination. Actin was used as a loading control. (b) Immunostaining for DN-erbB4 protein in coronal sections of adult corpus callosum shows expression only in white matter of Tg mice. (c) Immunostaining of cingulate cortex in adult Tg mice for DN-erbB4 (green) and PLP (red) shows overlap. Blue shows DAPI-stained nuclei. (d) Immunoprecipitation of erbB2 from corpus callosum followed by phosphotyrosine Western blot shows that erbB2 phosphorylation is reduced in the white matter of adult Tgs. (Scale bars: 100 μm in b and 20 μm in c.)
Fig. 2.
OL structure and number are altered in the absence of erbB signaling. (a) Representative EM of myelinated axons in the corpus callosum. (Insets) Higher magnification of myelin in WT and Tg animals. (b) Quantification of the g-ratio in WT (open bars) and Tg (filled bars) optic nerve (OPN) and corpus callosum (CC). Tg mice have thinner myelin sheaths than WTs (P = 0.031). (c) Representative images of PLP in situ hybridization in corpus callosum sections. (d) Quantification of PLP+ cells in corpus callosum shows a higher density of OLs in Tg mice (P = 0.007). (e) The density of PDGFαR+ OL progenitors is not altered in Tg mice (P = 0.36). (f) Three-dimensional reconstructions of representative WT and Tg frontal cortex OLs. For quantification of OL morphology see Table 1. Error bars represent SEM. (Scale bars: 80 nm in a, 26 nm in Insets, 50 μm in c, and 20 μm in f.)
Fig. 3.
Behavioral alterations in Tg mice. (a) Locomotor activity in the open field as a function of time in WT (open squares) and Tg (black diamonds) mice. Tg animals habituate to a greater extent (_F_1,4 = 6.28; P < 0.0001). (b) Tg mice spend less time in the center of the open-field chamber (P = 0.0004). (c) Tg mice spend less time on the open arms of an elevated plus maze (P = 0.033). (d) Tg mice take longer to investigate an intruder after repeated exposure in a social investigation test (_F_1,3 = 3.68; P = 0.02). (e) Tg mice attempt to mount intruder mice less frequently than WTs (_F_1,3 = 2.73; P = 0.05). (f) Tg mice sensitize more robustly to amphetamine than WT mice (_F_4,176 = 7.54; P < 0.001). Error bars represent SEM.
Fig. 4.
Dopaminergic neurotransmission is altered in Tg mice. (a) Autoradiography of D1-like and D2-like receptors and DAT binding on brain sections. For quantification see
SI Table 2
. (Scale bar: 4 mm.) (b) c-fos induction in the striatum in response to amphetamine is significantly higher in Tg mice (P = 0.04). (c) c-fos induction in the striatum in response to DHX is significantly higher in Tg mice (P = 0.01). (d) Representative traces of evoked dopamine release in nucleus accumbens in response to a 1-mA current pulse to the medial forebrain bundle. (e) Amplitude of evoked dopamine release is enhanced in Tg compared with WT mice (n = 10; 0.1 mA, P = 0.044; 1 mA, P = 0.007). Error bars represent SEM.
Similar articles
- Axonal neuregulin-1 regulates myelin sheath thickness.
Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA. Michailov GV, et al. Science. 2004 Apr 30;304(5671):700-3. doi: 10.1126/science.1095862. Epub 2004 Mar 25. Science. 2004. PMID: 15044753 - A functional role for EGFR signaling in myelination and remyelination.
Aguirre A, Dupree JL, Mangin JM, Gallo V. Aguirre A, et al. Nat Neurosci. 2007 Aug;10(8):990-1002. doi: 10.1038/nn1938. Epub 2007 Jul 8. Nat Neurosci. 2007. PMID: 17618276 - Neuroscience. The mysteries of myelin unwrapped.
ffrench-Constant C, Colognato H, Franklin RJ. ffrench-Constant C, et al. Science. 2004 Apr 30;304(5671):688-9. doi: 10.1126/science.1097851. Science. 2004. PMID: 15118149 No abstract available. - Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction.
Feng Y. Feng Y. Neurochem Res. 2008 Oct;33(10):1940-9. doi: 10.1007/s11064-008-9693-x. Epub 2008 Apr 11. Neurochem Res. 2008. PMID: 18404371 Review. - Neuregulin-1 and myelination.
Lemke G. Lemke G. Sci STKE. 2006 Mar 7;2006(325):pe11. doi: 10.1126/stke.3252006pe11. Sci STKE. 2006. PMID: 16522871 Review.
Cited by
- Axonal neurotransmitter release in the regulation of myelination.
Marshall-Phelps KLH, Almeida RG. Marshall-Phelps KLH, et al. Biosci Rep. 2024 Sep 25;44(9):BSR20231616. doi: 10.1042/BSR20231616. Biosci Rep. 2024. PMID: 39230890 Free PMC article. Review. - Translating Molecular Approaches to Oligodendrocyte-Mediated Neurological Circuit Modulation.
Song J, Saglam A, Zuchero JB, Buch VP. Song J, et al. Brain Sci. 2024 Jun 27;14(7):648. doi: 10.3390/brainsci14070648. Brain Sci. 2024. PMID: 39061389 Free PMC article. Review. - Dynamics of mature myelin.
Osso LA, Hughes EG. Osso LA, et al. Nat Neurosci. 2024 Aug;27(8):1449-1461. doi: 10.1038/s41593-024-01642-2. Epub 2024 May 21. Nat Neurosci. 2024. PMID: 38773349 Review. - The Genomic Intersection of Oligodendrocyte Dynamics in Schizophrenia and Aging Unravels Novel Pathological Mechanisms and Therapeutic Potentials.
Rivera AD, Normanton JR, Butt AM, Azim K. Rivera AD, et al. Int J Mol Sci. 2024 Apr 18;25(8):4452. doi: 10.3390/ijms25084452. Int J Mol Sci. 2024. PMID: 38674040 Free PMC article. Review. - Exploring hub genes and crucial pathways linked to oxidative stress in bipolar disorder depressive episodes through bioinformatics analysis.
Wu S, Hu H, Li Y, Ren Y. Wu S, et al. Front Psychiatry. 2024 Mar 6;15:1323527. doi: 10.3389/fpsyt.2024.1323527. eCollection 2024. Front Psychiatry. 2024. PMID: 38510807 Free PMC article.
References
- Corfas G, Roy K, Buxbaum JD. Nat Neurosci. 2004;7:575–580. - PubMed
- Norton N, Moskvina V, Morris DW, Bray NJ, Zammit S, Williams NM, Williams HJ, Preece AC, Dwyer S, Wilkinson JC, et al. Am J Med Genet B. 2006;141:96–101. - PubMed
- Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R. Am J Med Genet B. 2006;141:142–148. - PubMed
- Law AJ, Shannon Weickert C, Hyde TM, Kleinman JE, Harrison PJ. Neuroscience. 2004;127:125–136. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 MH66171/MH/NIMH NIH HHS/United States
- F31 NS048630/NS/NINDS NIH HHS/United States
- R01 NS35884/NS/NINDS NIH HHS/United States
- R01 NS035884/NS/NINDS NIH HHS/United States
- P50 MH066171/MH/NIMH NIH HHS/United States
- P30 HD018655/HD/NICHD NIH HHS/United States
- R43 MH070264/MH/NIMH NIH HHS/United States
- NS7473/NS/NINDS NIH HHS/United States
- T32 NS007473/NS/NINDS NIH HHS/United States
- R01 MH60131/MH/NIMH NIH HHS/United States
- R01 MH060131/MH/NIMH NIH HHS/United States
- P30-HD 18655/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous